Related Experiment Video
Updated: Jul 13, 2026

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
Effect of body mass index on outcome in pediatric heart transplant patients
Joseph W Rossano1, Michelle A Grenier, William J Dreyer
1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. jrossano@bcm.tmc.edu
Insights
Being underweight at the time of pediatric heart transplant is linked to poorer graft survival. Weight gain after transplant is common, and being overweight does not negatively impact survival.
Area of Science:
- Pediatric Cardiology
- Transplant Surgery
- Immunology
Background:
- Obesity and cachexia are known risk factors for adverse outcomes in adult transplant recipients.
- Limited data exists on the impact of body mass index (BMI) on outcomes in pediatric heart transplant patients.
Purpose of the Study:
- To investigate the association between body mass index (BMI) and long-term outcomes in pediatric heart transplant recipients.
- To determine if pre-transplant BMI influences graft survival in children.
Main Methods:
- Retrospective analysis of pediatric heart transplant patients (age > 2 years) from 1985 to 2004.
- Assessment of body mass index (BMI) at transplant and 1 year post-transplant.
- Evaluation of long-term graft survival based on weight groups.
Main Results:
- Underweight patients (< 5th percentile BMI) at transplant had significantly decreased graft survival (mean 6.7 years) compared to normal weight patients (mean 10.6 years).
- Overweight patients (> or = 95th percentile BMI) at transplant did not show decreased graft survival.
- Being underweight at transplant was identified as an independent predictor of reduced graft survival on multivariate analysis.
Conclusions:
- Weight gain is common post-transplant in pediatric heart recipients, with only 4% remaining underweight at 1 year.
- Graft survival in overweight pediatric heart transplant recipients was comparable to normal-weight patients.
- Pre-transplant underweight status is a significant independent risk factor for decreased graft survival in pediatric heart transplantation.
Background:
Obesity and cachexia are risk factors for adverse outcomes in adult transplant patients. However, little is known about the effects of body mass index (BMI) on outcomes in pediatric heart transplant patients.
Methods:
Patients > 2 years of age undergoing heart transplantation from 1985 to 2004 at our institution were included in this study. BMI was assessed at the time of transplant and at 1 year post-transplant. Long-term outcomes were assessed by weight group.
Results:
The cohort included 105 patients with a mean age at transplant of 9.6 +/- 5.3 years. The mean BMI percentile at the time of transplant was 39 +/- 34, with 22 (21%) patients underweight (< 5th percentile) and 8 (8%) patients overweight (> or = 95th percentile). Among patients surviving to 1 year (n = 92), the mean BMI percentile increased to 57 +/- 33 (p < 0.05). Overall graft survival was decreased in patients underweight at transplant, mean 6.7 years (95% confidence interval [CI] 3.6 to 9.9), vs normal weight patients, mean 10.6 years (95% CI 8.8 to 12.4) (p < 0.05). Patients overweight at transplant did not have decreased graft survival. Neither low nor high BMI at 1 year post-transplant was associated with adverse outcomes. On multivariate analysis, being underweight at transplant was an independent predictor of decreased graft survival (p = 0.03).
Conclusions:
Weight gain was nearly universal post-transplant with only 4% of patients underweight at 1 year. In the small number of patients overweight at transplant, graft survival was similar to normal-weight patients. Conversely, being underweight at transplant was an independent predictor of decreased graft survival.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drug Dosing: Obese Patients